SCHEMBL21861995

SCHEMBL21861995

CCC(C)C(=O)OCc1ccc(NC=O)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSB P07858 3/20 0.37
KMT2A Q03164 6/20 0.37
MEN1 O00255 5/20 0.37
LMNA P02545 1/20 0.37
ALDH1A1 P00352 3/20 0.36
DHODH Q02127 1/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CTSL P07711 1/20 0.36
CTSS P25774 1/20 0.36
MAPT P10636 2/20 0.35
GAA P10253 1/20 0.35
RAB9A P51151 1/20 0.35
KDM4E B2RXH2 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CA7 P43166 1/20 0.35
CA14 Q9ULX7 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
LTA4H P09960 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19502636 0.86 ROCK2 (0.41) CTSBKMT2AMEN1LMNAALDH1A1
SCHEMBL24760246 0.82 KMT2A (0.38) KMT2AMEN1LMNAALDH1A1CA1
SCHEMBL22198532 0.82 KMT2A (0.41) KMT2AMEN1LMNAALDH1A1CA1
SCHEMBL19503127 0.80 MAPT (0.41) KMT2AMEN1LMNAALDH1A1DHODH
SCHEMBL22990404 0.80 ALDH1A1 (0.55) KMT2AMEN1LMNAALDH1A1DHODH
SCHEMBL2742150 0.79 MEN1 (0.52) KMT2AMEN1LMNAALDH1A1CA1
SCHEMBL12116549 0.78 ALDH1A1 (0.45) KMT2AALDH1A1CA1CA2MAPT
SCHEMBL24164305 0.76 LMNA (0.43) KMT2AMEN1LMNAALDH1A1CA1
SCHEMBL22549263 0.76 ALDH1A1 (0.55) KMT2AMEN1LMNAALDH1A1DHODH
SCHEMBL12026774 0.76 CA1 (0.40) KMT2AMEN1ALDH1A1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020056192-A1 ANTIBODY CONJUGATES OF TOLL-LIKE RECEPTOR AGONISTS SILVERBACK THERAPEUTICS, INC. (US) 2020-03-19 WO disclosed